What is the nature of causality and evidence in pharmacology? On what grounds is causal assessment licensed in pharmacology? Do current evidence standards do justice to the purpose of risk prevention and safety? These are some of the questions behind the ERC-funded project Philosophy of Pharmacology: Safety, Statistical Standards, and Evidence amalgamation. The project has three objectives:
- To provide a foundational analysis on statistical/causal inference with a focus on the critical assessment of current practices in drug approval and pharmacosurveillance.
- To build a unified epistemic framework within which different kinds of evidence for pharmaceutical harm can be combined and used for decision: evidence amalgamation.
- To provide a theoretical framework for the development of new standards of drug evaluation.
The project is interdisciplinary and applies methods from the philosophy of science, in particular from the theory of causality and from the foundations of statistics, to pharmacology.